M&A
confidence high
sentiment neutral
materiality 1.00
BD to spin off Biosciences/Diagnostics, merge with Waters for $4B cash plus 39.2% stake
BECTON DICKINSON & CO
- BD receives $4B cash from SpinCo; BD shareholders get 39.2% of Waters post-merger; Waters holders get 60.8%.
- Transaction structured as Reverse Morris Trust: spin-off of SpinCo then merger with Waters subsidiary.
- Waters to pay $733M termination fee if deal falls under certain conditions; closing targeted by July 13, 2026.
- Conditions include HSR clearance, IRS private letter ruling, Waters shareholder approval, and financing completion.
- Post-closing Waters board to have 11-12 members; BD to designate 1-2 directors, Waters designates 10.